Cliff Asness: Education, Papers, Wife, Net Worth

Page 6 of 6

5. Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) saw Cliff Asness’ fund cut its stake by 14% to 4.91 million shares worth $650.10 million during the second quarter. There were 72 funds in our database long Johnson & Johnson (NYSE:JNJ) at the end of June, up from 70 funds a quarter earlier. AQR has held shares of Johnson & Johnson (NYSE:JNJ) since 2004, which is clear to see why, as the pharmaceutical giant is one of the safest bets on the healthcare sector. The company’s stock has more than doubled over the last decade and it is one of the few so-called “Dividend Kings”, which means that the company has been increasing its dividend for over 50 years in a row. From a valuation perspective, Johnson & Johnson (NYSE:JNJ) also seems to look attractive. It has a forward P/E of 17.10, which is one of the lowest of its peers among major drug manufacturers, while its dividend yield of 2.54% is one of the highest, with dividends being one of the main reasons why investors like the stock.

Follow Johnson & Johnson (NYSE:JNJ)

Disclosure: none

Page 6 of 6